Colipa launches new Web site
This article was originally published in The Rose Sheet
European Cosmetics Association's new public Web site at 1www.colipa.eu offers stakeholders - including decision-makers, regulators, the media and the public - in the EU and wider world "improved access to information about the cosmetics industry," trade group's Director-General Bertil Heerink says. "We are confident that this new site will improve the quality of dialogue, to which we attach so much importance." Site's "Safety & Science" section includes European Union legislation and safety assessment links, its "Well-Being" page provides an overview of personal-care benefits, while the "Using Cosmetics" section includes information on allergies and labeling and "how to keep products." The Personal Care Products Council reinvented itself and launched its consumer-oriented informational Web site, 2www.cosmeticsinfo.org, in late 2007 in the interest of greater transparency (3"The Rose Sheet" Dec. 3, 2007, p. 3)
You may also be interested in...
The Cosmetic, Toiletry and Fragrance Association has launched its much-anticipated informational Web site, adopted a new motto and changed its name to the Personal Care Products Council in a makeover highlighting its focus on science and the consumer, the group announces Nov. 29
Boston Scientific has agreed to pay $1.07bn to acquire Lumenis’ surgical laser business from Baring Private Equity Asia. See what Meghan Scanlon, president of Boston Scientific’s urology and pelvic health business, said about it here.
US Remains Conservative On Vaccine Dosing Regimens As CDC’s ACIP Highlights Minimal Comfort With Relying On Unproven Correlates
The Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices concerns about making COVID-19 vaccine dose regimen changes based on unproven immune correlates of protection could be a warning sign to sponsors about roadblocks they might face if updating vaccines to address viral variants or conducting pediatric studies relying on such surrogate endpoints.